Bei Akademie registrieren
Drägerwerk, DE0005550636

Drägerwerk stock trades 0.63 percent below its Xetra close: Q3 EBIT reaches EUR 48 million

Published on 10/18/2026 at 18:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Drägerwerk stock costs EUR 95.10 in weekend trading on October 18, 2026 versus the Xetra close of EUR 95.70. Q3 EBIT was EUR 48 million.

Quarterly figures and dates

  • Preliminary third-quarter EBIT reached EUR 48 million on October 14, 2026.
  • Drägerwerk stock trades in weekend trading at EUR 95.10 at 6:04 p.m. CEST on October 18, 2026, 0.63 percent below the Xetra close of October 16, 2026.
  • The next Xetra session is scheduled for October 19, 2026.
  • Third-quarter revenue totaled around EUR 851 million in 2026.
Flatlay mit Aktienzertifikat, ISIN DE0005550636, Gasmelder, Atemmaske und Stethoskop auf Marmor
Drägerwerk AG & Co. KGaA Aktienzertifikat ISIN DE0005550636 Gasmelder Atemmaske Stethoskop Flatlay-Arrangement, Illustration mit AI erstellt.

Drägerwerk stock trades in weekend trading at Lang & Schwarz at EUR 95.10 at 6:04 p.m. CEST on October 18, 2026, 0.63 percent below the Xetra close of October 16, 2026 at EUR 95.70. Drägerwerk reported preliminary third-quarter 2026 EBIT of around EUR 48 million on October 14, 2026, according to its EQS-distributed announcement.

Market context: Market report DAX.

The week in figures

The weekend price of EUR 95.10 is 0.63 percent below the Xetra close of EUR 95.70 on October 16, 2026. The Lang & Schwarz quote showed a bid of EUR 94.80 and an ask of EUR 95.40 at 6:04 p.m. CEST. The available weekly record also includes Drägerwerk’s preliminary third-quarter figures released on October 14, 2026.

Chronology of the week

On October 14, 2026, Drägerwerk said preliminary third-quarter revenue rose 2.1 percent nominally to around EUR 851 million. EBIT was around EUR 48 million, compared with EUR 56.7 million in the third quarter of 2025. The EBIT margin was around 5.6 percent, versus 6.8 percent a year earlier. The company’s EQS Newswire release said the 2026 forecast was confirmed.

For the first nine months of 2026, Dräger reported revenue of around EUR 2.454 billion and EBIT of around EUR 112 million. The company continued to expect currency-adjusted revenue growth of 2.0 percent to 6.0 percent and an EBIT margin of 6.0 percent to 8.0 percent for 2026, according to the EQS release.

Dates of the coming week

Drägerwerk said it will publish its quarterly statement on October 29, 2026. The next Xetra session is October 19, 2026.

The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CEST is shown by the continuously updated real-time quote of Drägerwerk stock.

Disclaimer...
en | DE0005550636 | DRäGERWERK | boerse | 70355427 | bgmi